Airsculpt Technologies Inc
NASDAQ:AIRS
Airsculpt Technologies Inc
NASDAQ:AIRS
Price:
4.31 USD
-7.51%
Market Closed
Updated:
May 21, 2024
P/E
Price to Earnings
Price to Earnings
158.5
Current
-38.3
Median
24.1
Industry
Higher
than median
Higher
than industry value
Price to Earnings (P/E) ratio is a valuation multiple that compares a company’s market capitalization to its net income. It indicates the dollar amount an investor can expect to invest in a company in order to receive $1 of that company’s earnings.
P/E
=158.5
Market Cap
/
248m
Net Income
1.6m
All Countries
| Market Cap | P/E | ||||
|---|---|---|---|---|---|
| US |
|
Airsculpt Technologies Inc
NASDAQ:AIRS
|
248m USD | 158.5 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
89B EUR | 26.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
94.7B USD | 26.2 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
71.9B USD | 9.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
17.4B USD | 40.3 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15.6B EUR | -49.5 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
16B USD | 19 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11.9B EUR | 24.6 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
11.8B EUR | 24.4 | |
| US |
|
DaVita Inc
NYSE:DVA
|
12.4B USD | 15.2 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | -18.6 |
P/E Forward Multiples
Forward P/E multiple is a version of the P/E ratio that uses forecasted net income for the P/E calculation. 1-Year, 2-Years, and 3-Years forwards use net income forecasts for 1, 2, and 3 years ahead, respectively.
1-Year Forward
P/E
31.7
2-Years Forward
P/E
12.7
3-Years Forward
P/E
6.8
You don't have any saved screeners yet
